Charles Swanton, FRCP, BSc, PhD, of The Francis Crick Institute and Cancer Research UK London Research Institute, London, UK, discusses…
Browsing: Acute Lymphoblastic Leukemia
Charles Swanton, FRCP, BSc, PhD, of The Francis Crick Institute and Cancer Research UK London Research Institute, London, UK, gives…
Charles Swanton, FRCP, BSc, PhD, of The Francis Crick Institute and Cancer Research UK London Research Institute, London, UK, gives…
Previously, risk reduction from treatment with endocrine therapy has been represented as a general percentage for all patients treated. Knowing…
At the European Cancer Congress (ECC) 2015, André Robidoux, MD, FRCSC, of Centre Hospitalier de l’Université de Montréal, Montreal, Canada,…
At the European Cancer Congress (ECC) 2015, Hendrik-Tobias Arkenau, MD, PhD, of Sarah Cannon Research Institute UK, London, UK, discusses…
Dr. Naughton discusses the bothersome side effects and serious safety risks associated with endocrine therapy. He emphasizes the need to…
At the European Cancer Congress (ECC) 2015, Charles Swanton, FRCP, BSc, PhD, of The Francis Crick Institute and Cancer Research…
At the European Cancer Congress (ECC) 2015, Hendrik-Tobias Arkenau, MD, PhD, of Sarah Cannon Research Institute UK, London, UK, discusses…
At the European Cancer Congress (ECC) 2015, Riccardo A. Audisio, MD, FRCS, of the University of Liverpool, St. Helens Teaching…
@OncEd Presents Dr. Nancy Zhu – Case-Based Discussion for Managing MDS Patients. This live webinar took place on September 10,…
At the European Cancer Congress (ECC) 2015, Charles Swanton, FRCP, BSc, PhD, of The Francis Crick Institute and Cancer Research…
At the European Cancer Congress (ECC) 2015, Keith M. Kerr, BSc, MB, ChB, FRCPath, FRCPE, of the University of Aberdeen,…
At the European Cancer Congress (ECC) 2015, Charles Swanton, FRCP, BSc, PhD, of The Francis Crick Institute and Cancer Research…
@OncEd Presents Dr. Martin Reck – ECC 2015 Immunotherapy Updates
@OncEd Presents Dr Luis Bruno – ECC 2015 GU Cancer Highlights (Portuguese Version)
@OncEd Presents Dr. Stephanie Snow – ECC 2015 Head and Neck Updates
@OncEd Presents Dr. Scott Berry – ICECREAM Trial
@OncED Presents Dr. Scott Berry – COMET Trial
@OncEd Presents Dr. Nadia Harbeck – PALOMA 3 Trial
@OncEd Presents Dr. Ralph Wong – Neuroendocrine Tumour Updates
@OncEd Presents Dr. Ramon Andrade de Mello – Hypermethylation of the TERT Promoter (Portuguese Version)
@OncEd Presents Dr. Ramon Andrade de Mello – Hypermethylation of the TERT Promoter
@OncEd Presents Dr. Silke Gillessen – SAKK 08/11 Study
@OncEd Presents Dr. Vladimir Milovanov – Predicting incomplete cytoreduction and aborted HIPEC in PC
@OncEd Presents Dr. Juan Pablo Marquez Manriquez – Multi-Antigen Vaccination for Colon Cancer Treatment and Prevention
@OncEd Presents Dr. Sunil Verma – ECC 2015 Breast Cancer Updates
@OncEd Presents Dr. Jeff Weber – Novel Combinations with Checkpoint Inhibitors
@OncEd Presents Dr. Stephen Doral Stefani – Access and Equity
@OncEd Presents Dr. Wolfgang Janni – DETECT Study
@OncEd Presents Dr. Jean Fayette – UNICANCER Trial
@OncEd Presents Dr Michael Untch – GEPARQUINTO Study
@OncEd Presents Dr. Fernando Rivera – PEAK Trial
At the European Cancer Congress (ECC) 2015, Mark Lawler, PhD, of Queens University Belfast, Belfast, UK, Richard Sullivan, MD, PhD,…
In patients with early stage breast cancer, there is a need to identify prognostic factors to determine the risk of…
@OncEd Presents Dr. Christos Sotiriou – NEOALTTO Trial
@OncEd Presents Dr. Linda Lindstrom – ST03 Trial
@OncEd Presents Dr. Neal Shore – TAK-385 Trial
@OncEd Presents Visualization and relaxation as anxiety reducing techniques – Dr. Andreas Charalambous. From ECC 2015 in Vienna, Austria.
At the European Cancer Congress (ECC) 2015, Hendrik-Tobias Arkenau, MD, PhD, of Sarah Cannon Research Institute UK, London, UK, discusses…
At the European Cancer Congress (ECC) 2015, Giorgio V. Scagliotti, MD, PhD, of the University of Turin, Turin, Italy, discusses…
Dr Naughton discusses challenges facing women who are evaluating extention of adjuvant endocrine treatment and how he finds Breast Cancer…
At the European Cancer Congress (ECC) 2015, Peter Naredi, MD, PhD, of the University of Gothenburg, Gothenburg, Sweden, chairs a…
European Cancer Patient Coalition (ECPC) is the largest European cancer patients’ umbrella organisation, representing 365 patient organisations in 40 European…
There is a growing divide in cancer healthcare and survivorship between populations across Europe. European Cancer Patient Coalition (ECPC), the…
At the European Cancer Congress (ECC) 2015, Neal Shore, MD, FACS, of Carolina Urologic Research Center, Myrtle Beach, SC, discusses…
European Cancer Patient Coalition (ECPC), the largest European cancer patients umbrella organisation, presented the paper, Europe of Disparities in Cancer,…
A meta-analysis was conducted to include 12 randomised trials and a total of 1,231 breast cancer patients receiving chemotherapy, with…
Genomic interventions may improve disease-risk stratification and patient-tailored treatment. At the European Cancer Congress (ECC) 2015, John Crown, MD, MBA,…
At the European Cancer Congress (ECC) 2015, John Crown, MD, MBA, of St Vincents University Hospital, Dublin, Ireland, discusses the…